These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

222 related articles for article (PubMed ID: 29351298)

  • 41. Vaccinia viruses isolated from skin infection in horses produced cutaneous and systemic disease in experimentally infected rabbits.
    Cargnelutti JF; Schmidt C; Masuda EK; Nogueira PR; Weiblen R; Flores EF
    Res Vet Sci; 2012 Oct; 93(2):1070-5. PubMed ID: 22244689
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Intranasal immunisation with defective adenovirus serotype 5 expressing the Venezuelan equine encephalitis virus E2 glycoprotein protects against airborne challenge with virulent virus.
    Phillpotts RJ; O'brien L; Appleton RE; Carr S; Bennett A
    Vaccine; 2005 Feb; 23(13):1615-23. PubMed ID: 15694514
    [TBL] [Abstract][Full Text] [Related]  

  • 43. An Alanine-to-Valine Substitution in the Residue 175 of Zika Virus NS2A Protein Affects Viral RNA Synthesis and Attenuates the Virus In Vivo.
    Márquez-Jurado S; Nogales A; Ávila-Pérez G; Iborra FJ; Martínez-Sobrido L; Almazán F
    Viruses; 2018 Oct; 10(10):. PubMed ID: 30301244
    [TBL] [Abstract][Full Text] [Related]  

  • 44. The De Novo Synthesis of Horsepox Virus: Implications for Biosecurity and Recommendations for Preventing the Reemergence of Smallpox.
    Koblentz GD
    Health Secur; 2017; 15(6):620-628. PubMed ID: 28836863
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Infectious cDNA clone of the RA27/3 vaccine strain of Rubella virus.
    Pugachev KV; Galinski MS; Frey TK
    Virology; 2000 Jul; 273(1):189-97. PubMed ID: 10891421
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Comprehensive evaluation of the adenovirus/alphavirus-replicon chimeric vector-based vaccine rAdV-SFV-E2 against classical swine fever.
    Sun Y; Tian DY; Li S; Meng QL; Zhao BB; Li Y; Li D; Ling LJ; Liao YJ; Qiu HJ
    Vaccine; 2013 Jan; 31(3):538-44. PubMed ID: 23153441
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Protection against herpes B virus infection in rabbits with a recombinant vaccinia virus expressing glycoprotein D.
    Bennett AM; Slomka MJ; Brown DW; Lloyd G; Mackett M
    J Med Virol; 1999 Jan; 57(1):47-56. PubMed ID: 9890421
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Robust intrapulmonary CD8 T cell responses and protection with an attenuated N1L deleted vaccinia virus.
    Mathew A; O'Bryan J; Marshall W; Kotwal GJ; Terajima M; Green S; Rothman AL; Ennis FA
    PLoS One; 2008 Oct; 3(10):e3323. PubMed ID: 18830408
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Recombinant Semliki Forest virus particles expressing louping ill virus antigens induce a better protective response than plasmid-based DNA vaccines or an inactivated whole particle vaccine.
    Fleeton MN; Liljeström P; Sheahan BJ; Atkins GJ
    J Gen Virol; 2000 Mar; 81(Pt 3):749-58. PubMed ID: 10675413
    [TBL] [Abstract][Full Text] [Related]  

  • 50. A Crimean-Congo hemorrhagic fever (CCHF) viral vaccine expressing nucleoprotein is immunogenic but fails to confer protection against lethal disease.
    Dowall SD; Buttigieg KR; Findlay-Wilson SJ; Rayner E; Pearson G; Miloszewska A; Graham VA; Carroll MW; Hewson R
    Hum Vaccin Immunother; 2016; 12(2):519-27. PubMed ID: 26309231
    [TBL] [Abstract][Full Text] [Related]  

  • 51. The Virology of Taterapox Virus In Vitro.
    Parker S; Camilo de Oliveira L; Lefkowitz EJ; Hendrickson RC; Bonjardim CA; Wold WSM; Hartzler H; Crump R; Buller RM
    Viruses; 2018 Aug; 10(9):. PubMed ID: 30158437
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Recombinant chimeric yellow fever-dengue type 2 virus is immunogenic and protective in nonhuman primates.
    Guirakhoo F; Weltzin R; Chambers TJ; Zhang ZX; Soike K; Ratterree M; Arroyo J; Georgakopoulos K; Catalan J; Monath TP
    J Virol; 2000 Jun; 74(12):5477-85. PubMed ID: 10823852
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Deletion of the
    Bravo Cruz AG; Han A; Roy EJ; Guzmán AB; Miller RJ; Driskell EA; O'Brien WD; Shisler JL
    J Virol; 2017 Aug; 91(15):. PubMed ID: 28490586
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Recombinant newcastle disease virus expressing a foreign viral antigen is attenuated and highly immunogenic in primates.
    Bukreyev A; Huang Z; Yang L; Elankumaran S; St Claire M; Murphy BR; Samal SK; Collins PL
    J Virol; 2005 Nov; 79(21):13275-84. PubMed ID: 16227250
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Construction and characterization of a replication-defective herpes simplex virus 2 ICP8 mutant strain and its use in immunization studies in a guinea pig model of genital disease.
    Da Costa XJ; Bourne N; Stanberry LR; Knipe DM
    Virology; 1997 May; 232(1):1-12. PubMed ID: 9185583
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Vaccinia virus-induced smallpox postvaccinal encephalitis in case of blood-brain barrier damage.
    Garcel A; Fauquette W; Dehouck MP; Crance JM; Favier AL
    Vaccine; 2012 Feb; 30(7):1397-405. PubMed ID: 22227123
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Understanding orthopoxvirus interference with host immune responses to inform novel vaccine design.
    Pickup DJ
    Expert Rev Vaccines; 2007 Feb; 6(1):87-95. PubMed ID: 17280481
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Evaluation of two strains of Marek's disease virus serotype 1 for the development of recombinant vaccines against very virulent infectious bursal disease virus.
    Li K; Liu Y; Liu C; Gao L; Gao Y; Zhang Y; Cui H; Qi X; Zhong L; Wang X
    Antiviral Res; 2017 Mar; 139():153-160. PubMed ID: 27908832
    [TBL] [Abstract][Full Text] [Related]  

  • 59. The nucleoprotein of Pichinde virus expressed by a vaccinia-Pichinde virus recombinant partially protects hamsters from lethal virus challenge.
    Ozols DY; Rawls WE; Rosenthal KL; Harnish DG
    Arch Virol; 1994; 139(1-2):23-36. PubMed ID: 7826212
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Attenuation of a vaccine strain of vaccinia virus via inactivation of interferon viroceptor.
    Dénes B; Gridley DS; Fodor N; Takátsy Z; Timiryasova TM; Fodor I
    J Gene Med; 2006 Jul; 8(7):814-23. PubMed ID: 16634110
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 12.